menuMenu
          • WORLDWIDE
          • CONTACT US
          • About Us
            close
            • Our Work
            • Our History
            • Media Contacts
          • Inventing for Life 
          • Our Operations
            close
            • Translational Medicine Research Centre
            • Manufacturing Division
            • Sales and Marketing
            • pp加速器国际版
            • Animal Health Innovation
            • Asia Pacific Regional Office
          • Responsibility
            close
            • Ethics and Integrity
            • Our Environment
            • Global Corporate Responsibility Report
          • Research
            close
            • Drug Discovery
            • Clinical Development
          • Careers 
          • About Us navigate_next
            • Our Work
            • 粉色app加速器
            • Media Contacts
            • Our Operations navigate_next
              • Translational Medicine Research Centre
              • Manufacturing Division
              • Sales and Marketing
              • Singapore IT Hub
              • Animal Health Innovation
              • pp加速器安卓
          • 粉色app加速器 navigate_next
            • Ethics and Integrity
            • pp加速器安卓
            • Global Corporate Responsibility Report
          • Research navigate_next
            • Drug Discovery
            • Clinical Development
          • Inventing for Life
          • pp加速器国际版

          The Translational Medicine Research Centre employs a range of cutting-edge technology platforms to support early drug discovery pipeline decisions.

          LEARN MORE pp加速器国际版

           
           

          TODAY’s MSD

          At the Forefront of a New Digital Age In Healthcare With state-of-the-art technologies, Singapore IT Hub aims to harness digital innovation for better healthcare outcomes in the region.

          LEARN MORE

           
           

          TODAY’s MSD

          It’s not just healthcare, but human care. At MSD Pharma (Singapore), we are inventing for life for our patients, through our partnerships, with our people.

          LEARN MORE

           
           
          pp加速器官网网页

          The Asia Pacific is a leading growth driver for today’s MSD. We are headquartered in Singapore to better serve our customers in the region.

          LEARN MORE

           
           

          TODAY’s MSD

          We manufacture and package products that we distribute to more than 163 markets.

          MSD is committed to providing patients and customers with a reliable supply of high-quality, safe and effective medicines and vaccines. Our global supply strategy leverages both our internal manufacturing capabilities and those of external manufacturers that provide specialized skills, expertise and various types of manufacturing services.

          LEARN MORE 蚂蚁app加速器

           
           

          With our focus on aquatic animal disease research, we are committed to provide solutions for the aquaculture industry in the Asia Pacific region and beyond.

          LEARN MORE pp加速器国际版

           
           

          SOCIAL @MSDInvents
          OTHER MSD SITES
           
           

          We remain dedicated to helping those impacted by #HurricaneMaria and the #MexicoEarthquake. http://t.co/0gxTche5ia

          We’re working to reduce our waste footprint to create a future w/ more beautiful land & less landfills:… http://t.co/SQknCRVUDu

          “What a great day! I am a proud partner of Your Cancer Game Plan and have more tips to share with you. Visit:… http://t.co/HKSBq99bDz

            • Connect with Us:
            • pp加速器手机版
            • pp加速器国际版下载
            • 粉色app加速器
           
           
          • OTHER MSD SITES
            MSD for Mothers pp加速器国际版
          • Corporate Responsibility 蚂蚁app加速器
            MSD Corporate Responsibility website chevron_right
            Transparency Disclosures pp加速器安卓
          • MSD Animal Health
          • MSD Manuals
          • Univadis (a service of MSD subsidiary Aptus Health) 旋风app加速器
           
           
           

          Copyright © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of MSD & Co., Inc. All rights reserved.

          This website is maintained by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey ("Merck") and is intended for use by individuals who are not residents of the U.S.

          • Forward-Looking Statement
          • Privacy
          • Terms of Use
          pp加速器
          Image: Circle Close Icon

          Forward-Looking Statement ×
           

          Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

          This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

          Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

          The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

          No Duty to Update

          The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.